NASDAQ · ALNY
ALNYLAM PHARMACEUTICALS INC (ALNY) Valuation & Financials
ALNYLAM PHARMACEUTICALS INC (ALNY) is listed on NASDAQ. Its market capitalization is about $29.3B. On trailing-twelve-month earnings the P/E ratio is 53.94, and the P/B ratio is 21.67. Return on equity is 40.2%. These figures are computed in-house from official filings and are reference information only.
Valuation & financial metrics
- Market cap
- $29.3B
- P/E
- 53.94
- P/B
- 21.67
- P/S
- 6.94
- EPS
- $4.06
- ROE
- 40.2%
Basis: Trailing twelve months · consolidated · controlling interest · 최근 4개 분기(TTM)
See the full analysis in Korean (AI committee, filings, earnings)Questions & answers
What is the P/E ratio of ALNYLAM PHARMACEUTICALS INC (ALNY)?
On a trailing-twelve-month basis, ALNY trades at a P/E ratio of 53.94. It is calculated as market capitalization divided by net income attributable to controlling interests, using official filings. Reference information only.
What is the market capitalization of ALNYLAM PHARMACEUTICALS INC?
ALNY has a market capitalization of about $29.3B. The figure moves with the share price and is refreshed each trading day.
Is this page investment advice?
No. Every figure on this page is factual reference information compiled from public filings. It is not investment advice, a price forecast, or a buy or sell recommendation. Investment decisions rest with the user.
All metrics, scores, and content provided by ChickenStock are reference information derived from market data. They are not investment advice or a solicitation to trade. Investment decisions and their consequences rest with the user.